These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9859966)

  • 1. Seroprevalence of HTLV-I and HTLV-II among a cohort of HIV-infected women and women at risk for HIV infection. Women's Interagency HIV Study.
    Telzak EE; Hershow R; Kalish LA; Hardy WD; Zuckerman E; Levine A; Delapenha R; DeHovitz J; Greenblatt RM; Anastos K
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(5):513-8. PubMed ID: 9859966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HTLV-I/II seropositivity in populations at high risk for HIV-1 infection in Cordoba City, Argentina.
    Medeot S; Nates S; Gallego S; Sileoni S; Maturano E; Recalde Y; Giordano M; Alvarez RB
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jun; 18(2):187-8. PubMed ID: 9637585
    [No Abstract]   [Full Text] [Related]  

  • 3. Patterns of HIV-1 and HTLV-I/II in intravenous drug abusers from the middle atlantic and central regions of the USA.
    Lee HH; Weiss SH; Brown LS; Mildvan D; Shorty V; Saravolatz L; Chu A; Ginzburg HM; Markowitz N; Des Jarlais DC
    J Infect Dis; 1990 Aug; 162(2):347-52. PubMed ID: 2373871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human T-lymphotropic virus (HTLV I-II) infection among patients in an inner-city emergency department.
    Kelen GD; DiGiovanna TA; Lofy L; Junkins E; Stein A; Sivertson KT; Lairmore M; Quinn TC
    Ann Intern Med; 1990 Sep; 113(5):368-72. PubMed ID: 2382919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low prevalence of human T-cell leukaemia virus-I and -II infection among drug users in Amsterdam, The Netherlands.
    van den Hoek JA; Al EJ; Huisman JG; Goudsmit J; Coutinho RA
    J Med Virol; 1991 Jun; 34(2):100-3. PubMed ID: 1890409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HTLV-1 and HTLV-2 infections in HIV-infected individuals from Santos, Brazil: seroprevalence and risk factors.
    Etzel A; Shibata GY; Rozman M; Jorge ML; Damas CD; Segurado AA
    J Acquir Immune Defic Syndr; 2001 Feb; 26(2):185-90. PubMed ID: 11242188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates.
    de la Fuente L; Toro C; Soriano V; Brugal MT; Vallejo F; Barrio G; Jiménez V; Silva T;
    J Clin Virol; 2006 Mar; 35(3):244-9. PubMed ID: 16143565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of human T cell lymphotropic virus type II infection, with or without human immunodeficiency virus type 1 coinfection, among US intravenous drug users.
    Briggs NC; Battjes RJ; Cantor KP; Blattner WA; Yellin FM; Wilson S; Ritz AL; Weiss SH; Goedert JJ
    J Infect Dis; 1995 Jul; 172(1):51-8. PubMed ID: 7797946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human T cell lymphotropic virus types I and II in intravenous drug users in San Francisco: risk factors associated with seropositivity.
    Feigal E; Murphy E; Vranizan K; Bacchetti P; Chaisson R; Drummond JE; Blattner W; McGrath M; Greenspan J; Moss A
    J Infect Dis; 1991 Jul; 164(1):36-42. PubMed ID: 2056217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroepidemiology and clinical aspects of human T-cell lymphotropic virus type I/II infection in a cohort of intravenous drug users in New York City.
    Brown LS; Chu A; Allain JP; Lee H; Cerney M; Nemoto T
    N Y State J Med; 1991 Mar; 91(3):93-7. PubMed ID: 2047026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HTLV-I and HTLV-II infections among HIV-1 seropositive patients in Sao Paulo, Brazil.
    de Araujo AC; Casseb JS; Neitzert E; de Souza ML; Mammano F; Del Mistro A; De Rossi A; Chieco-Bianchi L
    Eur J Epidemiol; 1994 Apr; 10(2):165-71. PubMed ID: 7813694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human T-lymphotropic virus type II seroprevalence among emergency department and clinic patients.
    Agranoff D; Varney K; Khayam-Bashi H; Murphy EL
    West J Med; 1996 Jun; 164(6):481-5. PubMed ID: 8764621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No proof of HTLV-I/II in intravenous drug abusers with a high rate of HIV-1 infection in central Thailand.
    Saguanwongse S; Muangpom A; Ruchusatsawat N; Wongcheree S; Warachit P; Miyamura K; Yamazaki S; Honda M
    Microbiol Immunol; 1996; 40(9):639-44. PubMed ID: 8908608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retroviral coinfections at a New Orleans HIV outpatient clinic.
    Bessinger R; Beilke M; Kissinger P; Jarrott C; Tabak OF
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jan; 14(1):67-71. PubMed ID: 8989213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HTLV-I/II seroprevalence and risk factors associated with infection in a blood donor population in Córdoba, Argentina].
    Gallego S; Maturano E; Recalde A; Gastaldello R; Sileoni S; Bepre H; Medeot S
    Rev Argent Microbiol; 2001; 33(3):182-6. PubMed ID: 11594010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The seroepidemiology of human T-lymphotropic viruses: types I and II in Europe: a prospective study of pregnant women.
    Taylor GP; Bodéus M; Courtois F; Pauli G; Del Mistro A; Machuca A; Padua E; Andersson S; Goubau P; Chieco-Bianchi L; Soriano V; Coste J; Ades AE; Weber JN
    J Acquir Immune Defic Syndr; 2005 Jan; 38(1):104-9. PubMed ID: 15608533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrovirus infections in a sample of injecting drug users in Rio de Janeiro City, Brazil: prevalence of HIV-1 subtypes, and co-infection with HTLV-I/II.
    Guimarães ML; Bastos FI; Telles PR; Galvão-Castro B; Diaz RS; Bongertz V; Morgado MG
    J Clin Virol; 2001 May; 21(2):143-51. PubMed ID: 11378495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of anti-HTLV I/II seroprevalence in healthy blood donors in Izmir region, Turkey].
    Sertöz R; Turhan A; Bozkurt H; Samlıoğlu P; Değirmenci A; Aydınok Y; Erensoy S
    Mikrobiyol Bul; 2010 Oct; 44(4):579-84. PubMed ID: 21063970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging role of HTLV-I/II and HIV-1 among intravenous drug users in Detroit.
    Ognjan AF; Lewandowski CA; Belian BT; Burczak J; Markowitz N; Lee H; Saravolatz LD
    Henry Ford Hosp Med J; 1992; 40(1-2):131-5. PubMed ID: 1428966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of human T cell leukemia virus in HIV antibody-negative populations in rural Cameroon.
    Machuca A; Wood O; Lee S; Daniel S; Rios M; Wolfe ND; Carr JK; Eitel MN; Tamoufe U; Torimiro JN; Burke D; Hewlett IK
    Clin Infect Dis; 2005 Jun; 40(11):1673-6. PubMed ID: 15889367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.